Company
Headquarters: Puning, China
Employees: 7,786
CN¥35.63 Billion
CNY as of Jan. 1, 2025
US$4.88 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥5.21 B |
| EBITDA | CN¥488.5 M |
| Gross Profit TTM | CN¥831.9 M |
| Profit Margin | 4.90% |
| Operating Margin | -3.31% |
| Quarterly Revenue Growth | 20.90% |
Kangmei Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600518 wb_incandescent